| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/27/2010 | CN100584944C Trimeresurus albolabris defibrase preparation method |
| 01/27/2010 | CN100584857C Process of high purity albumin production |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652025 Remedies for sepsis |
| 01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/21/2010 | WO2010007530A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2010006521A1 2-methyl-5h-pyrazolo[1,5-a][3,1]benzoxazin-5-imine compound, the preparation and the use thereof |
| 01/21/2010 | WO2010006485A1 Benzoxazinopyrazoles and their ring-opening compound |
| 01/21/2010 | WO2009134383A3 Vinyl substituted fatty acids |
| 01/21/2010 | WO2009045412A3 Methods of treatment using modified plasminogen activator inhibitor type-1 molecules |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016410 Methods and Compositions Related to Eosinophil Regulation |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016372 Benzimidazole Derivatives |
| 01/21/2010 | US20100016358 Gamma-globin inducer |
| 01/21/2010 | US20100016356 Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015684 Factor vii: remodeling and glycoconjugation of factor vii |
| 01/21/2010 | US20100015201 Implant with coating |
| 01/21/2010 | US20100015121 Inhibiting gs-fdh to modulate no bioactivity |
| 01/21/2010 | US20100015100 Differentiation of human embryonic stem cells |
| 01/21/2010 | US20100015065 Compositions for food, process for producing the same, and functional foods and drinks containing the same |
| 01/21/2010 | DE102008032361A1 Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie The use of factor VIII and vWF and vWF-containing concentrates for the treatment of induced platelet inhibitors coagulopathy |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2730975A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/20/2010 | EP2145900A1 Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation |
| 01/20/2010 | EP2145624A1 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP2144923A2 Methods of treatment using glycopegylated g-csf |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1204870B1 Method for determining physiological effects of hemoglobin |
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP0971724B1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/20/2010 | CN201384713Y Piperazine ferulate enteric-coated tablet |
| 01/20/2010 | CN201384712Y Sodium ferulate enteric-coated tablet |
| 01/20/2010 | CN100582123C Clexane and preparation method thereof |
| 01/20/2010 | CN100581577C Thrombus diminishing blood-pressure reducing preparation |
| 01/20/2010 | CN100581570C Traditional Chinese medicine decoction |
| 01/20/2010 | CN100581558C Preparation of blood-activating and pain-stopping capsules |
| 01/20/2010 | CN100581552C Compound puerarin for treating cardiovascular and cerebrovascular disease |
| 01/20/2010 | CN100581549C Sustained-release preparation containing hydrochlorothiazide and preparation method thereof |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648958 Factor VIII/vWF-complex and methods of purifying same |
| 01/14/2010 | WO2010005692A2 Insecticidal cyclic carbonyl amidines |
| 01/14/2010 | WO2010005480A2 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | WO2010005385A1 2-amino-6-alkyl substituted pyridine derivatives useful as p2y12 inhibitors 308 |
| 01/14/2010 | WO2010005384A1 Ketone pyridine analogues and their use in the treatment of cardiovascular disorders |
| 01/14/2010 | WO2010005087A1 Amidine derivative |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2010003687A1 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 01/14/2010 | WO2010003350A1 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2009124103A3 Combination therapies comprising par1 antagonists with par4 antagonists |
| 01/14/2010 | US20100010066 Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene |
| 01/14/2010 | US20100010060 Isoindolin-1-One-, Isoindolin-3-One- and Isoindolin-1,3-Dione-Derivatives and Use Thereof |
| 01/14/2010 | US20100010050 Formulations for the controlled release of agrochemical active agents |
| 01/14/2010 | US20100010017 Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 01/14/2010 | US20100009996 Methods and compositions for the treatment of metabolic disorders |
| 01/14/2010 | US20100009995 Maleate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 01/14/2010 | US20100009994 L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 01/14/2010 | US20100009939 Concurrent drugs |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009895 Method for selective localization of active agents at and in mitochondria and corresponding active agents |
| 01/14/2010 | US20100008988 Tablet compositions of amine polymers |
| 01/14/2010 | US20100008914 Methods and compositions for treating il-4 and il-13 related fibrosis related pathologies |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | DE102008045152A1 Künstliche Sauerstoffträger und ihre Verwendung Artificial oxygen carriers and their use |
| 01/14/2010 | CA2843880A1 Nutritive compositions and methods of using same |
| 01/14/2010 | CA2730316A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | CA2730290A1 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2728213A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | CA2637517A1 Cold storage of modified platelets |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143790A1 A purified recombinant batroxobin with high specific activity |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142509A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 01/13/2010 | EP1755642B1 Annexin v for preventing plaque rupture |
| 01/13/2010 | EP1422229B1 Porphyrin-metal complexes and oxygen infusions containing the same |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |